NSEDCP
HZNP

NJ State Employees Deferred Compensation Plan’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,000
Closed -$2.2M – 493
2023
Q3 		$2.2M Hold
19,000
– – 0.33% 70
2023
Q2 		$1.95M Buy
+19,000
New +$2M 0.28% 77

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's HZNP Position: Q4 2023 in Review

NJ State Employees Deferred Compensation Plan sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 19,000 shares — an estimated $2.2M sold.

NJ State Employees Deferred Compensation Plan first reported a position in HZNP in Q2 2023 and held it in 2 quarters. The position peaked at $2.2M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • NJ State Employees Deferred Compensation Plan reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 19,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.2M.
  • NJ State Employees Deferred Compensation Plan first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2023 and held it in 2 quarters.
  • NJ State Employees Deferred Compensation Plan's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.2M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2023, filed 2 Feb 2024.